Xinxiang Li
Xinxiang Li
Shanghai, Shanghai Municipality, China1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Lvosidenib (AK112) Combined With CapeOX and Radiotherapy in Patients With Unresectable Metastatic MSS-type Colorectal Cancer | Neoplasm Metastasis, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, colorectal carcinoma, metastatic malignant neoplasm, neoplasm | Not yet recruiting | Phase 2 | 2024-09-19 | NCT06593548 |